To further assess the therapeutic potential of ASO-induced exon skipping in correcting the CFTR-W1282X mutation, we analyzed the effects of ASO treatment on channel activity in differentiated primary human bronchial epithelial (hBE) cells isolated from a CF patient homozygous for CFTR-W1282X. The gene discussed is CFTR; the disease is cystic fibrosis.